Transforming molecular information
Go to content
Contact
IntegraGen on Twitter
IntegraGen on LinkedIn
IntegraGen - RSS feed
About Us
Company Overview
Management Team
Board of Directors
ISO 13485:2016 Certification
IntegraGen Genomics
miRpredX 31-3p
miRpredX 31-3p kit
Kit Contents
Testing Basics
Ordering Information
Documentation and Downloads
miR‐31‐3p and colorectal cancer
miR-31-3p Clinical data
miR-31-3p presentations and publications
Scientific Advisors
Oncology
miRpredX 31-3p
MERCURY
Lung Cancer
Oncology News
News and Events
Press releases
Latest News
Upcoming Events
Investors
Corporate Presentations
Share Information
Number of shares and voting rights
Press releases
Calendar for Publications
Financial Documents
Financial Reports
Liquidity Contract
Shareholder Meetings
Investor Contacts
Join our mailing list
Contact Us
Office locations
Need Directions?
Contact form
Join our mailing list
Careers
Learn more »
Experts in genome analysis
and bioinformatics
Learn more »
Molecular tumor profiling for translational & clinical research
Learn more »
Changing the way you analyze your exome data
Learn more »
IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
"Helping you to find"
Learn more
miRpredX 31-3p
The first positive theranostic test for patients with metastatic colorectal cancer
Learn more
Investors
Learn more about IntegraGen
Learn more
Latest news
// Archive
News
IntegraGen presents new data expanding application of miR-31 to stage III colon cancer during ESMO 2018
Press releases
IntegraGen Reports Financial Results for 1st Half of 2018
News
IntegraGen nominated for a 2018 PrixGalien MedStartup Award
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.
Ok
